196 related articles for article (PubMed ID: 22795618)
1. Keratin 17 as a therapeutic target for the treatment of psoriasis.
Fu M; Wang G
J Dermatol Sci; 2012 Sep; 67(3):161-5. PubMed ID: 22795618
[TBL] [Abstract][Full Text] [Related]
2. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
Shi X; Jin L; Dang E; Chang T; Feng Z; Liu Y; Wang G
J Invest Dermatol; 2011 Dec; 131(12):2401-8. PubMed ID: 21796151
[TBL] [Abstract][Full Text] [Related]
3. The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2.
Zhang W; Dang E; Shi X; Jin L; Feng Z; Hu L; Wu Y; Wang G
PLoS One; 2012; 7(7):e40797. PubMed ID: 22808266
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis.
Chang T; Sun L; Wang Y; Wang D; Li W; Li C; Gao T; Liu Y; Wang G
Exp Dermatol; 2011 Jul; 20(7):555-60. PubMed ID: 21355890
[TBL] [Abstract][Full Text] [Related]
5. Regulation of epidermal expression of keratin K17 in inflammatory skin diseases.
Komine M; Freedberg IM; Blumenberg M
J Invest Dermatol; 1996 Oct; 107(4):569-75. PubMed ID: 8823363
[TBL] [Abstract][Full Text] [Related]
6. Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis.
Shen Z; Chen L; Liu YF; Gao TW; Wang G; Fan XL; Fan JY; Fan PS; Li CY; Liu B; Dang YP; Li CX
J Am Acad Dermatol; 2006 Jun; 54(6):992-1002. PubMed ID: 16713453
[TBL] [Abstract][Full Text] [Related]
7. E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.
Yang L; Jin L; Ke Y; Fan X; Zhang T; Zhang C; Bian H; Wang G
J Invest Dermatol; 2018 Dec; 138(12):2568-2577. PubMed ID: 29859926
[TBL] [Abstract][Full Text] [Related]
8. Keratin 17: a critical player in the pathogenesis of psoriasis.
Jin L; Wang G
Med Res Rev; 2014 Mar; 34(2):438-54. PubMed ID: 23722817
[TBL] [Abstract][Full Text] [Related]
9. NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways.
Zhuang Y; Han C; Li B; Jin L; Dang E; Fang H; Qiao H; Wang G
Arch Dermatol Res; 2018 Mar; 310(2):147-156. PubMed ID: 29349514
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL
Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695
[TBL] [Abstract][Full Text] [Related]
11. Keratin 17 in psoriasis: Current understanding and future perspectives.
Lin Y; Zhang W; Li B; Wang G
Semin Cell Dev Biol; 2022 Aug; 128():112-119. PubMed ID: 34229948
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17.
Yang L; Fan X; Cui T; Dang E; Wang G
J Invest Dermatol; 2017 Oct; 137(10):2168-2176. PubMed ID: 28576737
[TBL] [Abstract][Full Text] [Related]
13. TGFβ/SMAD/microRNA-486-3p Signaling Axis Mediates Keratin 17 Expression and Keratinocyte Hyperproliferation in Psoriasis.
Jiang M; Sun Z; Dang E; Li B; Fang H; Li J; Gao L; Zhang K; Wang G
J Invest Dermatol; 2017 Oct; 137(10):2177-2186. PubMed ID: 28642156
[TBL] [Abstract][Full Text] [Related]
14. Shikonin inhibits IFN-γ-induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling.
Liu L; Wu Y; Cao K; Xu YY; Gao XH; Chen HD; Geng L
Int J Clin Exp Pathol; 2015; 8(8):9202-7. PubMed ID: 26464667
[TBL] [Abstract][Full Text] [Related]
15. RBM15-Mediated m6A Modification of K17 Affects Keratinocytes Response to IL-17A Stimulation in Psoriasis.
Fu M; Zhou B; Shi N; Dong R; Chen Y
Ann Clin Lab Sci; 2023 Jul; 53(4):529-538. PubMed ID: 37625827
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
Honma M; Minami-Hori M; Takahashi H; Iizuka H
J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: exploration of pharmaco- and gene-therapeutic effects.
Bockelmann R; Horn T; Gollnick H; Bonnekoh B
Skin Pharmacol Physiol; 2005; 18(1):42-54. PubMed ID: 15608502
[TBL] [Abstract][Full Text] [Related]
18. WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17.
Ti C; Chen H; Zhou W; Bian A; Hu P; Miao Y; Shao T; Liu M; Chen Y; Yi Z
Int Immunopharmacol; 2024 Jan; 127():111344. PubMed ID: 38086269
[TBL] [Abstract][Full Text] [Related]
19. Effect of Calcipotriol on IFN-γ-Induced Keratin 17 Expression in Immortalized Human Epidermal Keratinocyte Cells.
Zhang J; Fang H; Wang R; Dang E; Jiang M; Wang G
Med Sci Monit; 2017 Dec; 23():6049-6056. PubMed ID: 29269725
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
